CGEM logo

Cullinan Oncology (CGEM) Company Overview

Profile

Full Name:

Cullinan Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

January 8, 2021

Indexes:

Not included

Description:

Cullinan Oncology (CGEM) is a biopharmaceutical company focused on developing innovative cancer therapies. They aim to create targeted treatments that improve patient outcomes by leveraging advanced science and technology. CGEM collaborates with partners to bring new drugs to market, addressing unmet medical needs in oncology.

Events Calendar

Earnings

Next earnings date:

May 15, 2025

Recent quarterly earnings:

Feb 27, 2025

Recent annual earnings:

Feb 27, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 28, 25 HC Wainwright & Co.
Buy
Oct 24, 24 UBS
Buy
Aug 9, 24 Wedbush
Outperform
Jun 3, 24 HC Wainwright & Co.
Buy
May 24, 24 HC Wainwright & Co.
Buy
May 16, 24 Wedbush
Outperform
May 16, 24 HC Wainwright & Co.
Buy
May 1, 24 Stifel
Buy
Apr 17, 24 JonesTrading
Buy
Apr 17, 24 BTIG
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Cullinan Oncology?
  • Does Cullinan Oncology pay dividends?
  • What sector is Cullinan Oncology in?
  • What industry is Cullinan Oncology in?
  • What country is Cullinan Oncology based in?
  • When did Cullinan Oncology go public?
  • Is Cullinan Oncology in the S&P 500?
  • Is Cullinan Oncology in the NASDAQ 100?
  • Is Cullinan Oncology in the Dow Jones?
  • When was Cullinan Oncology's last earnings report?
  • When does Cullinan Oncology report earnings?
  • Should I buy Cullinan Oncology stock now?

What is the ticker symbol for Cullinan Oncology?

The ticker symbol for Cullinan Oncology is NASDAQ:CGEM

Does Cullinan Oncology pay dividends?

No, Cullinan Oncology does not pay dividends

What sector is Cullinan Oncology in?

Cullinan Oncology is in the Healthcare sector

What industry is Cullinan Oncology in?

Cullinan Oncology is in the Biotechnology industry

What country is Cullinan Oncology based in?

Cullinan Oncology is headquartered in United States

When did Cullinan Oncology go public?

Cullinan Oncology's initial public offering (IPO) was on January 8, 2021

Is Cullinan Oncology in the S&P 500?

No, Cullinan Oncology is not included in the S&P 500 index

Is Cullinan Oncology in the NASDAQ 100?

No, Cullinan Oncology is not included in the NASDAQ 100 index

Is Cullinan Oncology in the Dow Jones?

No, Cullinan Oncology is not included in the Dow Jones index

When was Cullinan Oncology's last earnings report?

Cullinan Oncology's most recent earnings report was on Feb 27, 2025

When does Cullinan Oncology report earnings?

The next expected earnings date for Cullinan Oncology is May 15, 2025

Should I buy Cullinan Oncology stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions